Chris M. Parry

4.3k total citations
42 papers, 1.3k citations indexed

About

Chris M. Parry is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Chris M. Parry has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 25 papers in Virology and 12 papers in Epidemiology. Recurrent topics in Chris M. Parry's work include HIV Research and Treatment (25 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (17 papers). Chris M. Parry is often cited by papers focused on HIV Research and Treatment (25 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (17 papers). Chris M. Parry collaborates with scholars based in United Kingdom, Uganda and United States. Chris M. Parry's co-authors include Hanna K de Jong, W. Joost Wiersinga, Tom van der Poll, Deenan Pillay, J. Pedro Simas, Stacey Efstathiou, Vincent P. Smith, A. C. Minson, Antonio Alcamı́ and Claudia Stewart and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Chris M. Parry

40 papers receiving 1.3k citations

Peers

Countries citing papers authored by Chris M. Parry

Since Specialization

Citations

This map shows the geographic impact of Chris M. Parry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris M. Parry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris M. Parry more than expected).

Fields of papers citing papers by Chris M. Parry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris M. Parry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris M. Parry. The network helps show where Chris M. Parry may publish in the future.

Co-authorship network of co-authors of Chris M. Parry

This figure shows the co-authorship network connecting the top 25 collaborators of Chris M. Parry. A scholar is included among the top collaborators of Chris M. Parry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris M. Parry. Chris M. Parry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and Safety Outcomes in Adults Initiating Dolutegravir/Lamivudine With High Viral Load in the GEMINI-1/-2 and STAT Trials 2025 ·Open Forum Infectious Diseases ·Charlotte-Paige Rolle, José Ramón Arribas, Roberto Ortiz, Mark Underwood, Chris M. Parry, Richard Grove, (unknown), (unknown), (unknown)	0
2	Assessing the Virologic Impact of Archived Resistance in the Dolutegravir/Lamivudine 2-Drug Regimen HIV-1 Switch Study TANGO through Week 144 2023 ·Viruses ·Ruolan Wang, Jonathan Wright, (unknown), Mounir Ait‐Khaled, (unknown), Chris M. Parry, Thomas A. Lutz, Daniel Podzamczer, Richard D. Moore, Miguel Górgolas Hernández-Mora, Clifford Kinder, Brian Wynne, Jean van Wyk, Mark Underwood	1
3	Isotopic Radiolabeling of the Antiretroviral Drug [18F]Dolutegravir for Pharmacokinetic PET Imaging 2022 ·Pharmaceuticals ·(unknown), Sébastien Goutal, Thomas A. Bonasera, (unknown), Delphine Desjardins, Roger Le Grand, Chris M. Parry, Nicolas Tournier, Bertrand Kühnast, Fabien Caillé	3
4	Activation of coagulation and endothelium with concurrent impairment of anticoagulant mechanisms in patients with typhoid fever 2018 ·Journal of Infection ·Hanna K de Jong, Chris M. Parry, Thomas W. van der Vaart, Liesbeth M. Kager, (unknown), Rapeephan R. Maude, Lalith Wijedoru, Aniruddha Ghose, (unknown), (unknown), Arjen M. Dondorp, Stephen Baker, M. Abul Faiz, Joost C.M. Meijers, W. Joost Wiersinga	8
5	HIV-1 transmission networks in high risk fishing communities on the shores of Lake Victoria in Uganda: A phylogenetic and epidemiological approach 2017 ·PLoS ONE ·Sylvia Kiwuwa-Muyingo, (unknown), Deogratius Ssemwanga, Pauliina Ilmonen, Harr Freeya Njai, Nicaise Ndembi, Chris M. Parry, Paul Kato Kitandwe, Gershim Asiki, Juliet Mpendo, (unknown), Janet Seeley, (unknown), Fred Lyagoba, Anatoli Kamali, Pontiano Kaleebu	28
6	Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy 2016 ·Antimicrobial Agents and Chemotherapy ·Jennifer Giandhari, Adriaan E. Basson, (unknown), Chris M. Parry, Patricia A. Cane, Ashraf Coovadia, Louise Kuhn, Gillian Hunt, Lynn Morris	14
7	Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial 2015 ·PLoS ONE ·(unknown), Chris M. Parry, Adele McCormick, Anne Kapaata, Fred Lyagoba, Pontiano Kaleebu, Charles F. Gilks, Ruth Goodall, Moira Spyer, Cissy Kityo, Deenan Pillay, Ravindra K. Gupta, (unknown)	21
8	Human immunodeficiency virus Tat associates with a specific set of cellular RNAs 2014 ·Retrovirology ·Russell D. Bouwman, Anne Palser, Chris M. Parry, Eve Coulter, Jane Rasaiyaah, Paul Kellam, Richard G. Jenner	12
9	Calprotectin and Lactoferrin Faecal Levels in Patients with Clostridium difficile Infection (CDI): A Prospective Cohort Study 2014 ·PLoS ONE ·Andrew Swale, Fábio Miyajima, Paul Roberts, Amanda J. Hall, (unknown), Mike Beadsworth, Nicholas J. Beeching, Ruwanthi Kolamunnage‐Dona, Chris M. Parry, Munir Pirmohamed	43
10	Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study 2013 ·Journal of Antimicrobial Chemotherapy ·David Dolling, David Dunn, (unknown), Deenan Pillay, Jean L. Mbisa, Chris M. Parry, Frank A. Post, Caroline Sabin, Patricia A. Cane, (unknown)	11
11	HIV-1 Subtype Distribution Trends and Evidence of Transmission Clusters Among Incident Cases in a Rural Clinical Cohort in Southwest Uganda, 2004–2010 2012 ·AIDS Research and Human Retroviruses ·Anne Kapaata, (unknown), Deogratius Ssemwanga, Brian Magambo, (unknown), Jonathan Levin, Billy N. Mayanja, Claire M. Mugasa, Chris M. Parry, Pontiano Kaleebu	13
12	Low Drug Resistance Levels Among Drug-Naive Individuals with Recent HIV Type 1 Infection in a Rural Clinical Cohort in Southwestern Uganda 2012 ·AIDS Research and Human Retroviruses ·Deogratius Ssemwanga, Anne Kapaata, (unknown), Brian Magambo, (unknown), Billy N. Mayanja, Chris M. Parry, Pontiano Kaleebu	8
13	Host–Pathogen Interaction in Invasive Salmonellosis 2012 ·PLoS Pathogens ·Hanna K de Jong, Chris M. Parry, Tom van der Poll, W. Joost Wiersinga	241
14	The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains 2011 ·Retrovirology ·Jean L. Mbisa, Ravindra K. Gupta, (unknown), Veronica Mulenga, (unknown), Chifumbe Chintu, Chris M. Parry, Diana M. Gibb, Sarah Walker, Patricia A. Cane, Deenan Pillay	10
15	Full-length HIV-1 Gag determines protease inhibitor susceptibility within in-vitro assays 2010 ·AIDS ·Ravindra K. Gupta, Arinder Kohli, Adele McCormick, Greg J. Towers, Deenan Pillay, Chris M. Parry	59
16	Antibodies to the Vi capsule of Salmonella Typhi in the serum of typhoid patients and healthy control subjects from a typhoid endemic region 2008 ·The Journal of Infection in Developing Countries ·John Wain, Deborah House, Vo A. Ho, To S. Diep, Nguyen Tran Chinh, Phan Van Be Bay, Ha Vinh, (unknown), Chris M. Parry, Gordon Dougan, Nicholas J. White, Jeremy Farrar, Tran Tinh Hien	17
17	The role of the polymerase chain reaction in the diagnosis of bacterial meningitis in Vietnam 2004 ·Annals of Tropical Medicine and Parasitology ·(unknown), (unknown), To S. Diep, Chris M. Parry, Tran Tinh Hien, Jeremy Farrar	7
18	Different effects of a single amino acid substitution on three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutant of human immunodeficiency virus type 1 2001 ·Archives of Virology ·Lesley McLain, Jeffrey L. Brown, Linda Cheung, (unknown), Chris M. Parry, Timothy D. Jones, Susan M. Cleveland, Nigel J. Dimmock	12
19	Production of Long-Lived Neutralizing Antibodies to HIV-1 IIIB in Mice with a Vaccinia Recombinant Virus-Infected Cell Vaccine Expressing gp160 1994 ·AIDS Research and Human Retroviruses ·Chris M. Parry, Lesley McLain, Nigel J. Dimmock	6
20	Salmonella dublin infection of a prosthetic vascular graft successfully treated with ciprofloxacin 1991 ·Journal of Infection ·Chris M. Parry, J. Cheesbrough, G Corcoran	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact